Sayan Chakraborty is an Assistant Professor of Oncology at the Department of Pharmacology & Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. He received his M.Sc. Degree in Biochemistry at the University of Calcutta, Kolkata, India in 2008. In 2012, he completed his doctoral training in Microbiology and Immunology at Rosalind Franklin University of Medicine and Science, North Chicago, IL, focusing on the entry, signaling, and trafficking of oncogenic Human Herpesvirus-8. Subsequently, he pursued his postdoctoral studies at the Institute of Molecular and Cell Biology in Singapore, where he discovered an oncogenic role for the proteoglycan Agrin in liver cancer before establishing his independent research lab at Roswell Park. He has been an Associate member of the American Association for Cancer Research (AACR) since 2016. Dr. Chakraborty's lab investigates the emerging role of extracellular matrix proteins in regulating the tumor microenvironment and has published numerous seminal research papers in Nature Communications, Cell Reports Medicine, and Advanced Science.